The severity of LPS induced inflammatory injury is negatively associated with the functional liver mass after LPS injection in rat model

Abstract

BackgroundHigh levels of serum lipopolysaccharide (LPS) were observed in sepsis patients with liver injury and high mortality. However, the role of liver in modulation LPS induced inflammatory injury was ill investigated. In the present study, the severity of LPS induced inflammatory response was observed after liver resection or portal branch occlusion to decreasing functional liver mass. The local and systemic damage was observed to investigate the role of liver in modulation inflammatory injury.MethodsFirst, 30%, 70%, and 90% partial hepatectomy (PH) were performed, and serum TNF-α, survival rate, and hepatic LPS uptake was observed. Second, LPS-exposure of the functional liver mass was decreased by selectively blocking the RL prior to LPS-injection, which was given 30 min before a 70% PH, and the inflammatory response was compared in the occluded and the non-occluded liver. The control group was subjected to LPS injection 30 min prior to liver resection without blocking the RL transiently. The serum TNF-α, ALT, AST, creatinine levels, and urea levels, survival rate, hepatic LPS uptake, and hepatic inflammatory cytokines was observed.ResultsThe decreasing of functional liver mass after 90%, 70%, and 30% PH was associated with decreased serum TNF-α, survival rate, and increased hepatic LPS uptake after LPS injection. Occluding the right lobes (RL) prior to LPS administration reversed the liver injury caused by 70% PH, indicated by 100% survival rate and decreased liver and kidney injury, and systemic inflammatory response. The induction of inflammatory response in occluding liver lobes were lower than un-occluding liver lobes.ConclusionsThe severity of the LPS-induced systemic inflammatory injury is determined by functional liver volume. This observation suggests that the liver is the central organ for the initiation of the inflammatory response, and is involved in causing a severe SIRS with systemic damage and death.Electronic supplementary materialThe online version of this article (10.1186/s12950-018-0197-4) contains supplementary material, which is available to authorized users.

Biodistribution and Pharmacokinectics of Liposomes and Exosomes in a Mouse Model of Sepsis

“…The toxic issues of LPS are mediated by cytokines like TNF-α, interleukin 1 (IL-1), and IL-6 released by LPS-activated host cells, such as neutrophils and macrophages. Several studies have shown that initial pro-inflammatory cytokines increase rapidly within 30 min after LPS injection [31,32]. Our recent cellular biodistribution findings also confirm the significant therapeutic effect of exosome carrying srIKB during the early stage of sepsis before the immunosuppressive state [30].…”

Long non-coding RNA CASC7 Contributes to the Progression of Sepsis-Induced Liver Injury by Targeting miR-217/TLR4 Axis

“…However, the correlation of lncRNA CASC7 with miR-217 and TLR4 in the modulation of sepsis-induced liver injury is still elusive. Lipopolysaccharide (LPS) serves as the endotoxin that is issued by bacterial membranes and interacts with receptors on the surface of endothelial cells, whereby working as a noxious factor that produces acute in ammation [25]. LPS has been identi ed to cause sepsis by modulating the oxidative stress or in ammatory factors, and the growth of endothelial cells [26].…”

New Biscembranoids Sardigitolides A–D and Known Cembranoid-Related Compounds from Sarcophyton digitatum: Isolation, Structure Elucidation, and Bioactivities

“…In most cases, the inflammatory response helps the organism to clear the LPS or pathogen. However, the violent inflammation caused by overproduced LPS could lead to tissue damage [ 28 ]. In the present study, the inhibitory effect of isolates 1 – 8 against the enhanced production of inflammatory factors in LPS-treated murine macrophage J774A.1 cells was examined.…”